Regulus Therapeutics
RGLS
#9143
Rank
โ‚น8.00 B
Marketcap
โ‚น120.84
Share price
1.45%
Change (1 day)
-38.86%
Change (1 year)

Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Volume in USD (price x number of shares), data since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น0.06 M-99.06%
2024โ‚น6.61 M4258.4%
2023โ‚น0.15 M-85.22%
2022โ‚น1.02 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น0.14 Bโ‚น0.24 B๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น0.96 Mโ‚น47.53 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น26.58 Mโ‚น75.58 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น24.59 Mโ‚น0.13 B๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น9.55 Mโ‚น33.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.19 Mโ‚น6.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.17 Bโ‚น0.49 B๐Ÿ‡บ๐Ÿ‡ธ USA